BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10536740)

  • 1. IRB review of psychiatric medication discontinuation and symptom-provoking studies.
    Rosenstein DL
    Biol Psychiatry; 1999 Oct; 46(8):1039-43. PubMed ID: 10536740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication discontinuation and symptom provocation in research: a consumer and family perspective.
    Hall LL
    Biol Psychiatry; 1999 Oct; 46(8):1017-20. PubMed ID: 10536737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatric research ethics: an overview of evolving guidelines and current ethical dilemmas in the study of mental illness.
    Roberts LW; Roberts B
    Biol Psychiatry; 1999 Oct; 46(8):1025-38. PubMed ID: 10536739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical considerations in psychopharmacological research involving decisionally impaired subjects.
    Rosenstein DL; Miller FG
    Psychopharmacology (Berl); 2003 Dec; 171(1):92-7. PubMed ID: 12774188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom provocation studies in psychiatric disorders: scientific value, risks, and future.
    D'Souza DC; Berman RM; Krystal JH; Charney DS
    Biol Psychiatry; 1999 Oct; 46(8):1060-80. PubMed ID: 10536743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The controversy over challenge and discontinuation studies: perspective from a consumer-psychiatrist.
    Vogel-Scibilia SE
    Biol Psychiatry; 1999 Oct; 46(8):1021-4. PubMed ID: 10536738
    [No Abstract]   [Full Text] [Related]  

  • 8. Protection of persons with mental disorders from research risk: a response to the report of the National Bioethics Advisory Commission.
    Oldham JM; Haimowitz S; Delano SJ
    Arch Gen Psychiatry; 1999 Aug; 56(8):688-93. PubMed ID: 10435600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protecting vulnerable research subjects without unduly constraining neuropsychiatric research.
    Miller FG; Fins JJ
    Arch Gen Psychiatry; 1999 Aug; 56(8):701-2; discussion 703-4. PubMed ID: 10435603
    [No Abstract]   [Full Text] [Related]  

  • 10. Institutional Review Board issues related to special populations.
    Ferraro FR; Orvedal L; Plaud JJ
    J Gen Psychol; 1998 Apr; 125(2):156-64. PubMed ID: 9778838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenges of IRB review and human subjects protections in practice-based research.
    Wolf LE; Croughan M; Lo B
    Med Care; 2002 Jun; 40(6):521-9. PubMed ID: 12021678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining risk in pediatric research with no prospect of direct benefit: time for a national consensus on the interpretation of federal regulations.
    Fisher CB; Kornetsky SZ; Prentice ED
    Am J Bioeth; 2007 Mar; 7(3):5-10. PubMed ID: 17366219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of institutional support in protecting human research subjects.
    Sugarman J
    Acad Med; 2000 Jul; 75(7):687-92. PubMed ID: 10926018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inconsistency and institutional review boards.
    Goldman J; Katz MD
    JAMA; 1982 Jul; 248(2):197-202. PubMed ID: 7045428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Informed consent for research on stored blood and tissue samples: a survey of institutional review board practices.
    White MT; Gamm J
    Account Res; 2002; 9(1):1-16. PubMed ID: 12705242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic discontinuation in clinical and research settings: scientific issues and ethical dilemmas.
    Jeste DV; Palmer BW; Harris MJ
    Biol Psychiatry; 1999 Oct; 46(8):1050-9. PubMed ID: 10536742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practice-based research network studies and institutional review boards: two new issues.
    Yawn BP; Graham DG; Bertram SL; Kurland MJ; Dietrich AJ; Wollan PC; Brandt EC; Huff JM; Pace WD
    J Am Board Fam Med; 2009; 22(4):453-60. PubMed ID: 19587261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The costs of an institutional review board.
    Brown JH; Schoenfeld LS; Allan PW
    J Med Educ; 1979 Apr; 54(4):294-9. PubMed ID: 430531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protecting subjects and fostering research. Striking the proper balance.
    Hirschfeld RM; Winslade W; Krause TL
    Arch Gen Psychiatry; 1997 Feb; 54(2):121-3. PubMed ID: 9040279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Institutional review board approval and publication of human research results.
    Amdur RJ; Biddle C
    JAMA; 1997 Mar; 277(11):909-14. PubMed ID: 9062330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.